Cardiovascular and obesity studies demonstrate that elevated circulating Cer can be decreased using cholesterol-lowering drugs (statins and PCSK9 inhibitors) and exercise35–37. Here, PCSK9 is linked to obesity due to melanocortin 4 receptor deficiency.